Our initial analysis showed that tumor cell viability decreased by approximately 40%, when treated with ≤5.0 μM, VS-6063, a chemical inhibitor of active FAK which blocks its Y397 autophosphorylation (Supplementary Figure S2A). Here, PTK2 is linked to neoplasm.